Significant efficacy of 2-chlorodeoxyadenosine± rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/24/9/2434/518455/mdt181.pdf
Reference26 articles.
1. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC);Troussard;Br J Haematol,1996
2. Marginal zone B cell lymphoma: a clinical comparison of nodal and mucosa associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project;Nathwani;J Clin Oncol,1999
3. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients;Berger;Blood,2000
4. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity;Thieblemont;Lancet Oncol,2003
5. Splenectomy influences bone marrow infiltration in patients with splenic marginal zone lymphoma with or without villous lymphocytes;Franco;Cancer,2001
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study;Haematologica;2024-03-14
2. Splenisches Marginalzonenlymphom;Indolente Lymphome;2023
3. Risk-tailored treatment of splenic marginal zone lymphoma;Anti-Cancer Drugs;2021-08-16
4. Splenic Marginal Zone Lymphoma;Hematologic Malignancies;2021
5. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Annals of Oncology;2020-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3